ARCHEGOS MEDICAL IMAGING LIMITED
Opportunity 75/100 (strong), bankability 65/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Biggest value-creation lever: Broaden director team. Sole director creates succession risk and reduces buyer comfort. Appoint a second director or strong #2. Most likely exit: share sale to pe / searcher (73/100).
Data confidence
Overall: medium (67/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Key financials
1 year extracted from filed iXBRL accountsFinancials
Extracted from Companies House accounts · IFRS| Metric | 2025-05-31 |
|---|---|
| Average employees | 200 |
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
- • 1 address
- • 1 address
Corporate timeline (7 events)Click to expand
- 2026-03-08📍change-registered-office-address-company-with-date-old-address-new-addressaddress · AD01
- 2025-08-25📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2025-03-26➕FUNG, Ming Wai appointedsecretary
- 2025-03-26📄appoint-person-secretary-company-with-name-dateofficers · AP03
- 2024-05-30🏢Company incorporatedAs ARCHEGOS MEDICAL IMAGING LIMITED
- 2024-05-30➕CHING, Alex Sik Chung, Dr. appointeddirector
- 2024-05-30📄incorporation-companyincorporation · NEWINC
Owner dependency
The business appears inseparable from the founder. Acquisition without a serious earn-out or meaningful transition period would likely destroy value.
- +Sole director: Only one active director — all governance concentrated on one person.
- +Senior director age: Director aged approximately 61 — approaching natural succession window.
- +Young company: Only 1.9 years old — management layer unlikely to be developed.
Succession & seller-readiness
Multiple signals suggest succession is on the horizon. Candidate for proactive outreach.
- secondaryFounder aged 58+: Senior director is approximately 61. Early succession window.
- primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.
Red flags
cleanShareholders & ownership
2 active beneficial owners| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Dr. Alex Sik Chung Ching Individual · Hong Konger · DOB 10/1965 · age 61 | 50–75% | 50–75% | board control50-75% shares · 50-75% voting · board control | 30/05/2024 |
Ms Ming Wai Fung Individual · Hong Konger · DOB 10/1968 · age 58 | 25–50% | 25–50% | 25-50% shares · 25-50% voting | 30/05/2024 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Similar companies
Active · Healthcare & medical · G postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| AR DENTAL LIMITED→ SC400032 · est 2011 · no financials extracted | — | — | — | — | 14y | — | — |
| ARDPEATON LIMITED→ SC780810 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
| ARICOM SATELLITE LIMITED→ SC678887 · est 2020 · no financials extracted | — | — | — | — | 5y | — | — |
| ARRAN PHARMACY LIMITED→ SC222920 · est 2001 · no financials extracted | — | — | — | — | 24y | — | — |
| ASHPHARM GLASGOW LTD→ SC628555 · est 2019 · no financials extracted | — | — | — | — | 6y | — | — |
| AURORA WOMEN'S MEDICAL LTD→ SC881744 · est 2026 · no financials extracted | — | — | — | — | — | — | — |
| AVISTAR MEDICAL LTD→ SC864683 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| AWSC LIMITED→ SC636346 · est 2019 · no financials extracted | — | — | — | — | 6y | — | — |
| AXON PAIN CLINICS LIMITED→ SC782268 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
| AYMAN & MARTIN LIMITED→ SC723846 · est 2022 · no financials extracted | — | — | — | — | 4y | — | — |
| AYNI GLA LIMITED→ SC783076 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
| AYPLUS MEDICS LIMITED→ SC792280 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
8 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (2 active · 0 resigned)
Click a director name to see their full track record across all companies.